---
title: 'Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1
  and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation
  for the treatment of dry eye disease'
date: '2024-11-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39607474/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241128174912&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The pooled analysis confirmed that the water-free ciclosporin
  0.1% solution is effective in improving ocular surface staining after 2 weeks of
  treatment to a clinically relevant extent in more than 50% of patients in the overall
  population and subgroups. With an early onset and good tolerability, the product
  has the potential to address an unmet medical need in ...'
disable_comments: true
---
CONCLUSION: The pooled analysis confirmed that the water-free ciclosporin 0.1% solution is effective in improving ocular surface staining after 2 weeks of treatment to a clinically relevant extent in more than 50% of patients in the overall population and subgroups. With an early onset and good tolerability, the product has the potential to address an unmet medical need in ...